News

NOV-205 is an injectable, small-molecule proprietary formulation of oxidised glutathione and inosine that acts as a hepatoprotective agent with immunomodulating and anti-inflammatory properties. The ongoing US Phase 2

Uveitis is an inflammatory condition of the internal structures of the eye that can lead to cataract, glaucoma, scarring, pain, photophobia, and even permanent loss of vision when

The study is the second Phase III clinical study being conducted in collaboration with Cosmo Technologies, a subsidiary of Cosmo Pharmaceuticals, as part of the budesonide MMX Phase

Ondansetron RapidFilm is an oral thin film formulation of ondansetron, a serotonin 5-HT3 receptor antagonist that is commonly used to treat and prevent nausea and vomiting caused by

Quintiles said that the new Phase I unit is expected to draw on the existing experience of Quintiles staff in India, including their cardiology group, the expertise of

Gross profit increased 208.6% year-over-year to $27.3m, representing a gross margin of 72.7% as compared to 67.2% a year ago. The gross profit and margin increases were primarily

GT said that the study, which is the basis for seeking FDA approval, also indicated that nearly 40% of women without disease could have avoided potentially painful and

Arena Pharma said that APD916 was efficacious in multiple preclinical models, and the data suggest that it has potential utility in the treatment of narcolepsy with or without

The acquisition of ‘i-pill’ will strengthen Piramal’s OTC portfolio which has consumer brands such as Lacto Calamine skin care range, Supractiv Complete, Saridon and Polycrol antacid. ‘i-pil’ is